MedTrace Logo

Brief Transdiagnostic Treatment for Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) in South Africa

NCT06289621 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-07-17

No results posted yet for this study

Summary

The purpose of this study is to examine the use of a brief transdiagnostic treatment for anxiety disorders and (post-traumatic stress disorder (PTSD) in South Africa. The intervention will be delivered by non-specialist providers (e.g., nurses) in primary care clinics. The brief intervention group will be compared to an enhanced standard care control group.

Conditions

  • Anxiety Disorders
  • Post-traumatic Stress Disorder

Interventions

BEHAVIORAL

False Safety Behavioral Elimination Treatment (FSET)

5-session transdiagnostic treatment for anxiety disorders and post-traumatic stress disorder (PTSD)

BEHAVIORAL

Enhanced Standard Care

Participants in the enhanced standard care control group will receive treatment as usual and a list referrals.

Sponsors & Collaborators

  • University of Stellenbosch

    collaborator OTHER

  • Fogarty International Center of the National Institute of Health

    collaborator NIH

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-08
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06289621 on ClinicalTrials.gov